Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Objective We investigated the relationships between glucocorticoid use, disease activity, and changes in body mass index (BMI) in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Methods We analyzed AAV patients enrolled in the Rituximab in AAV trial. Glucocorticoid use...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis care & research (2010) 2017-07, Vol.69 (7), p.1004-1010
Hauptverfasser:	Wallace, Zachary S., Miloslavsky, Eli M., Cascino, Matthew, Unizony, Sebastian H., Lu, Na, Hoffman, Gary S., Kallenberg, Cees G. M., Langford, Carol A., Merkel, Peter A., Monach, Paul A., Seo, Philip, Spiera, Robert, St.Clair, E. William, Specks, Ulrich, Brunetta, Paul, Choi, Hyon K., Stone, John H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravenous Adult Aged Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - blood Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy Antibodies, Antineutrophil Cytoplasmic - blood Antirheumatic Agents - administration & dosage Antirheumatic Agents - adverse effects Body composition Body Composition - drug effects Body Composition - physiology Body mass Body mass index Colon Disease Progression Drug Therapy, Combination Female Glucocorticoids Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Granulomatosis Health risk assessment Humans Immunotherapy Male Middle Aged Monoclonal antibodies Remission Induction - methods Rituximab Rituximab - administration & dosage Rituximab - adverse effects Treatment Outcome Vasculitis Wegener's granulomatosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!